Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DH03	INVANZ	B	Ertapenem - 1g	1g	Injectable concentrated powder for solution	3,785,604 L.L
B03AC	IVIRON	G	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable concentrated solution	1,745,203 L.L
L01CE02	IRINOTECAN GP PHARM	G	Irinotecan HCl trihydrate - 100mg/5ml	100mg/5ml	Injectable concentrated solution	5,239,642 L.L
J06BB01	IMMUNORHO	BioHuman	Human anti-D (rh) immunoglobulin - 300mcg	300mcg	Injectable dry powder+diluent	5,794,649 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	3,014,239 L.L
A02BC01	IPPROTON	G	Omeprazole - 40mg	40mg	Injectable lyophilised powder	6,533,762 L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
L04AB02	IXIFI	BioTech	Infliximab - 100mg	100mg	Injectable powder for concentrate for solution	L.L
L04AB02	IXIFI	BioTech	Infliximab - 100mg	100mg	Injectable powder for concentrate for solution	23,911,751 L.L
J01DH51	IMILASTIN	G	Imipenem - 500mg, Cilastatin - 500mg		Injectable powder for solution	6,101,612 L.L
J01DH51	IMIPENEM-CILASTATIN LABATEC	G	Imipenem (monohydrate) - 500mg, Cilastatin (sodium) - 500mg		Injectable powder for solution	8,922,845 L.L
J01DH51	IMIPENEME CILASTATINE PANPHARMA	G	Imipenem (monohydrate) - 500mg, Cilastatin (sodium) - 500mg		Injectable powder for solution	9,421,088 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 2.5g/50ml	2.5g/50ml	Injectable solution	17,011,323 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	28,622,366 L.L
J06BA02	IMMUNOREL	BioHuman	Human normal immunoglobulin - 5g/100ml	5%	Injectable solution	29,700,912 L.L
J06BA02	IMMUNOREL	BioHuman	Human normal immunoglobulin - 2.5g/50ml	5%	Injectable solution	14,850,456 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 10g/200ml	10g/200ml	Injectable solution	55,897,163 L.L
N05CD08	IPNODIS MEDIS	G	Midazolam - 5mg/ml	5mg/ml	Injectable solution	565,758 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 1g/20ml	1g/20ml	Injectable solution	7,474,948 L.L
J06BB04	IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB	BioHuman	Hepatitis B immunoglobulin (human) - 100UI/ml	100UI/ml	Injectable solution	6,853,730 L.L
J06BB04	IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB	BioHuman	Hepatitis B immunoglobulin (human) - 500UI/5ml	500UI/5ml	Injectable solution	26,599,935 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	193,513 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	190,826 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 400mg/100ml	400mg/100ml	Injectable solution	231,141 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 200mg/50ml	200mg/50ml	Injectable solution	161,261 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 600mg/100ml	600mg/100ml	Injectable solution	550,975 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	188,772 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	174,553 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L